search
Back to results

Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire

Primary Purpose

Malaria

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Alpha-cypermethrin and PBO LLIN
Alpha-cypermethrin and Clorfenapyr LLIN
Alpha-cypermethrin only LLIN
Sponsored by
London School of Hygiene and Tropical Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Malaria focused on measuring Anopheles density, Entomological inoculation rate, Malaria case incidence, Malaria infection prevalence

Eligibility Criteria

6 Months - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: For adults: willing to participate and provide consent For children: Having a parents/adult caregiver willing to provide written consent for the household and clinical survey and assent for children over 10 Residing in the village over the last 3 months Be aged 6 months to 9 years old at time of recruitment (for the cohort) Exclusion Criteria: Children who are expected to be non-resident over the period of study will be excluded (for the cohort) Dwelling not found or vacant during the survey (for prevalence and entomological surveys) No adult caregiver capable to give informed consent (All activities) Habitants/selected participants severely ill

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    Active Comparator

    Arm Label

    Py-PBO LLIN

    Py-CFP LLIN

    Py LLIN

    Arm Description

    Veeralin is a long-lasting net of 130 deniers containing the pyrethroid insecticide alpha-cypermethrin 6.0 g/kg (216 mg/m2) and the synergist piperonyl butoxide (PBO) 2.2 g/kg (79.2 mg/m2) and manufactured by VKA polymers.

    Interceptor® G2 is a long-lasting dual insecticide treated nets of 100 deniers combining Alpha-cypermethrin 2.4 g/kg (100 mg/m2) and Chlorfenapyr 4.8 g/kg (200 mg/m2) manufactured by BASF

    MAGNet® is a long-lasting net of 150 deniers containing the pyrethroid insecticide alpha-cypermethrin 5.8 g/kg (261 mg/m2) only and manufactured by VKA polymers.

    Outcomes

    Primary Outcome Measures

    malaria case incidence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Incidence of malaria cases (fever above 37.5C or history of a fever in the last 48 hours and a positive RDT) in children aged 6 months to 10 years.

    Secondary Outcome Measures

    Malaria infection prevalence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Malaria infection prevalence (by RDT) in the study population of all ages
    Malaria infection prevalence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Malaria infection prevalence (by RDT) in the study population of all ages
    Malaria infection prevalence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Malaria infection prevalence (by RDT) in the study population of all ages
    Vector Density per person per night using human indoor and outdoor landing catches
    Indoor and outdoor Anopheles density per night per person
    Sporozoite rate in Anopheles detected using Enzyme Linked Immuno-Sorbent Assay (ELISA) circumsporozoite protein technique. landing catches
    Proportion of Anopheles with malaria circumsporozoites in salivary gland
    Mean number of Plasmodium spp infective malaria vectors collected per person per night
    Entomological inoculation rate measure as vector density x sporozoite rate

    Full Information

    First Posted
    February 27, 2023
    Last Updated
    March 21, 2023
    Sponsor
    London School of Hygiene and Tropical Medicine
    Collaborators
    Institut Pierre Richet, University of Ottawa, University of Nevada, Las Vegas
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05796193
    Brief Title
    Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire
    Official Title
    Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 2023 (Anticipated)
    Primary Completion Date
    July 2024 (Anticipated)
    Study Completion Date
    December 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    London School of Hygiene and Tropical Medicine
    Collaborators
    Institut Pierre Richet, University of Ottawa, University of Nevada, Las Vegas

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The investigator plan to conduct a three-arm cluster-randomized control trial which compares two next generation of long-lasting Insecticidal Nets (LLINs); Veeralin®LLIN (PBO-py LLIN), Interceptor G2 (chlorfenapyr-py LLIN) to a standard py-LLIN in the department of Tiebissou Southern Bouake city, central Côte d'Ivoire. The primary objective of the project is to evaluate the efficacy of chlorfenapyr-pyrethroid and piperonyl-butoxide (PBO) synergist-pyrethroid LLINs on malaria case incidence in children aged 6 months to 10 years compared to standard pyrethroid-only LLINs. The secondary objectives are to evaluate the efficacy of the two intervention LLINs compared to the standard LLIN on a) malaria infection prevalence in the general population (both children and adults), b) vector density and c) entomological inoculation rate (EIR) (as a proxy for malaria transmission). In addition, changes in phenotypic resistance intensity and selection for molecular resistance mechanisms at baseline and 12 months post-LLIN distribution, in sentinel villages in each treatment arm will be investigate. It is vital to demonstrate that these next generation LLINs which are becoming the standard of care in Sub Saharan AFRICA, are superior to standard py-LLIN in the most extreme resistance areas as this is likely where alternative interventions will be most needed to keep malaria control on track. The trial will generate the first epidemiological evidence on the efficacy of PBO nets compared to py-LLIN in West Africa.
    Detailed Description
    Background: The massive scale-up of long-lasting insecticidal nets (LLIN) has led to a major reduction in malaria burden in many sub-Saharan African (SSA) countries. This progress is threatened by the wide scale selection of insecticide resistant malaria vectors. Study site: The study will be conducted in the department of Tiebissou (Gbeke Region in Lac district) Southern Bouake city, central Côte d'Ivoire. The Lac district is characterized by intense indoor malaria transmission with a prevalence of malaria reaching 51.3% in 2021 in children of under 5 years of age and extremely high pyrethroid resistance intensity in the main malaria vectors Anopheles gambiae s.s. and An. coluzzii. Study design: Three-arm superiority, single blinded, cluster-randomised trial with village as the unit of randomisation. The arms consist of; 1/ Veeralin LLIN, a net combining the synergist PBO and the pyrethroid alpha-cypermethrin, 2/Interceptor G2, a mixture LLIN incorporating two adulticides with different modes of action; chlorfenapyr and a pyrethroid (alpha-cypermethrin), and 3/ the control arm: MAGNet LLIN, an alpha-cypermethrin-only LLIN. Activities/Sample size: A total of 33 villages (1 village = 1 cluster) with an average of 200 households will be identified and mapped. Nets will be distributed at a central point following national guidelines with 1 net for every 2 people. To compare incidence of malaria cases between each intervention study arm and the control arm, a cohort of 50 children (45 + 5 to account for loss to follow up) will be recruited per cluster in 33 clusters for 12 months follow up to be able to detect a 35% relative reduction in malaria cases per child per year (rate ratio 0.65) between the intervention and the reference arms, assuming transmission in the control arm is 1.2 malaria cases per year with a coefficient of variation of 0.29 between clusters. The children will be visited twice a month during the transmission season (April to November) and once a month during the dry season. Malaria infection prevalence cross-sectional surveys will be conducted, at baseline, 6 and 12 months after LLIN distribution. 50 people of all ages will be randomly selected from each of the 33 clusters (11 clusters per arm x 3 arms) and tested for malaria using RDT. The study will have 80% power to detect a relative 35% lower prevalence (prevalence ratio 0.65 in each intervention arm (VEERALLIN or Interceptor G2) relative to standard LLIN, assuming a prevalence of 50% in the control arm and a coefficient of variation of 0.3. Vector density over 12 months will be followed using Human Landing Collection (HLC) indoor and outdoor with collection in 6 households in every cluster every 2 months. Assuming a mean mosquito density of 28 in the control arm, and a 60% reduction in mosquitoes in the intervention arms, with a coefficient of variation of 0.55 between clusters, this will give 80% power to detect differences at each timepoint. Insecticide resistance intensity will be monitored at baseline and post intervention using adapted CDC bottle assays. The mechanism involved in resistance to pyrethroid and chlorfenapyr will be screened.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Malaria
    Keywords
    Anopheles density, Entomological inoculation rate, Malaria case incidence, Malaria infection prevalence

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    1650 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Py-PBO LLIN
    Arm Type
    Experimental
    Arm Description
    Veeralin is a long-lasting net of 130 deniers containing the pyrethroid insecticide alpha-cypermethrin 6.0 g/kg (216 mg/m2) and the synergist piperonyl butoxide (PBO) 2.2 g/kg (79.2 mg/m2) and manufactured by VKA polymers.
    Arm Title
    Py-CFP LLIN
    Arm Type
    Experimental
    Arm Description
    Interceptor® G2 is a long-lasting dual insecticide treated nets of 100 deniers combining Alpha-cypermethrin 2.4 g/kg (100 mg/m2) and Chlorfenapyr 4.8 g/kg (200 mg/m2) manufactured by BASF
    Arm Title
    Py LLIN
    Arm Type
    Active Comparator
    Arm Description
    MAGNet® is a long-lasting net of 150 deniers containing the pyrethroid insecticide alpha-cypermethrin 5.8 g/kg (261 mg/m2) only and manufactured by VKA polymers.
    Intervention Type
    Other
    Intervention Name(s)
    Alpha-cypermethrin and PBO LLIN
    Intervention Description
    Veeralin Long lasting insecticidal net with Alpha-cypermethrin Pyrethroid insecticide and PBO
    Intervention Type
    Other
    Intervention Name(s)
    Alpha-cypermethrin and Clorfenapyr LLIN
    Intervention Description
    Interceptor G2 dual active ingredient LLIN with with Alpha-cypermethrin Pyrethroid insecticide and Clorfenapyr
    Intervention Type
    Other
    Intervention Name(s)
    Alpha-cypermethrin only LLIN
    Intervention Description
    reference: standard pyrethroid LLIN
    Primary Outcome Measure Information:
    Title
    malaria case incidence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Description
    Incidence of malaria cases (fever above 37.5C or history of a fever in the last 48 hours and a positive RDT) in children aged 6 months to 10 years.
    Time Frame
    Over one year follow up
    Secondary Outcome Measure Information:
    Title
    Malaria infection prevalence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Description
    Malaria infection prevalence (by RDT) in the study population of all ages
    Time Frame
    Baseline
    Title
    Malaria infection prevalence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Description
    Malaria infection prevalence (by RDT) in the study population of all ages
    Time Frame
    6 months post intervention
    Title
    Malaria infection prevalence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]
    Description
    Malaria infection prevalence (by RDT) in the study population of all ages
    Time Frame
    12 months post intervention
    Title
    Vector Density per person per night using human indoor and outdoor landing catches
    Description
    Indoor and outdoor Anopheles density per night per person
    Time Frame
    Over one year follow up
    Title
    Sporozoite rate in Anopheles detected using Enzyme Linked Immuno-Sorbent Assay (ELISA) circumsporozoite protein technique. landing catches
    Description
    Proportion of Anopheles with malaria circumsporozoites in salivary gland
    Time Frame
    Over one year follow up
    Title
    Mean number of Plasmodium spp infective malaria vectors collected per person per night
    Description
    Entomological inoculation rate measure as vector density x sporozoite rate
    Time Frame
    Over one year follow up
    Other Pre-specified Outcome Measures:
    Title
    gSG6-P1 IgG seroprevalence using ELISA technique
    Description
    Serological responses to mosquito salivary peptides: Blood spots on filter paper will be utilized to measure the level of antibodies in residents blood as a proxy for exposure to mosquito bites
    Time Frame
    baseline
    Title
    gSG6-P1 IgG seroprevalence using ELISA technique
    Description
    Serological responses to mosquito salivary peptides: Blood spots on filter paper will be utilized to measure the level of antibodies in residents blood as a proxy for exposure to mosquito bites
    Time Frame
    12 months post intervention
    Title
    30 minutes mortality in wild Anopheles post exposure to various concentration insecticide in CDC bottle assay
    Description
    Phenotypic resistance to alpha-cypermethrin, PBO + alpha-cypermethrin and chlorfenapyr using WHO cylinder and CDC bottle bioassays will be conducted
    Time Frame
    Baseline
    Title
    24 hours mortality in wild Anopheles post exposure to various concentration insecticide in CDC bottle assay
    Description
    Phenotypic resistance to alpha-cypermethrin, PBO + alpha-cypermethrin and chlorfenapyr using WHO cylinder and CDC bottle bioassays will be conducted
    Time Frame
    Baseline
    Title
    72 hours mortality in wild Anopheles post exposure to various concentration insecticide in CDC bottle assay
    Description
    Phenotypic resistance to alpha-cypermethrin, PBO + alpha-cypermethrin and chlorfenapyr using WHO cylinder and CDC bottle bioassays will be conducted
    Time Frame
    Baseline
    Title
    30 minutes mortality in wild Anopheles post exposure to various concentration insecticide in CDC bottle assay
    Description
    Phenotypic resistance to alpha-cypermethrin, PBO + alpha-cypermethrin and chlorfenapyr using WHO cylinder and CDC bottle bioassays will be conducted
    Time Frame
    12 months post intervention
    Title
    24 hours mortality in wild Anopheles post exposure to various concentration insecticide in CDC bottle assay
    Description
    Phenotypic resistance to alpha-cypermethrin, PBO + alpha-cypermethrin and chlorfenapyr using WHO cylinder and CDC bottle bioassays will be conducted
    Time Frame
    12 months post intervention
    Title
    72 hours mortality in wild Anopheles post exposure to various concentration insecticide in CDC bottle assay
    Description
    Phenotypic resistance to alpha-cypermethrin, PBO + alpha-cypermethrin and chlorfenapyr using WHO cylinder and CDC bottle bioassays will be conducted
    Time Frame
    12 months post intervention
    Title
    Relative fold change in expression of metabolic genes
    Description
    Selection for resistance will be monitored by measuring changes in levels of metabolic enzyme expression between wild population of Anopheles and susceptible reference Anopheles
    Time Frame
    Baseline
    Title
    Relative fold change in expression of metabolic genes
    Description
    Selection for resistance will be monitored by measuring changes in levels of metabolic enzyme expression between wild population of Anopheles and susceptible reference Anopheles
    Time Frame
    12 months post intervention
    Title
    Concentration of PBO, alpha-cypermethrin and Chlorfenapyr in g per kg in mosquito net
    Description
    Concentration of chemical will be assessed by HPLC
    Time Frame
    Before net distribution
    Title
    24 hours and 72 hours mortality in a susceptible colony of Anopheles gambiae after exposure to new pieces of mosquito nets
    Description
    Bio-efficacy testing will be conducted in standard WHO cone bio-assay and/or tunnel test
    Time Frame
    Before net distribution
    Title
    24 hours and 72 hours mortality in a resistant colony of Anopheles gambiae after exposure to new pieces of mosquito nets
    Description
    Bio-efficacy testing will be conducted in standard WHO cone bio-assay and/or tunnel test
    Time Frame
    Before net distribution

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Months
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: For adults: willing to participate and provide consent For children: Having a parents/adult caregiver willing to provide written consent for the household and clinical survey and assent for children over 10 Residing in the village over the last 3 months Be aged 6 months to 9 years old at time of recruitment (for the cohort) Exclusion Criteria: Children who are expected to be non-resident over the period of study will be excluded (for the cohort) Dwelling not found or vacant during the survey (for prevalence and entomological surveys) No adult caregiver capable to give informed consent (All activities) Habitants/selected participants severely ill
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Raphael NGUESSAN, PhD
    Phone
    +225 0779404001
    Email
    raphael.n'guessan@lshtm.ac.uk
    First Name & Middle Initial & Last Name or Official Title & Degree
    Aphonsine KOFFI, PhD
    Phone
    +225 0707620886
    Email
    koffi_alphonsine@yahoo.fr

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes

    Learn more about this trial

    Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire

    We'll reach out to this number within 24 hrs